Please assess the completion status of the following clinical trial:

Trial Title: Increasing Naloxone Access for Persons Who Use Opioids

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age or older~* Current or past six months illicit use of opioids~* Electronic device access for online survey completion~* Willing to provide email address to receive survey link and compensation~* Able to read and speak English~* Willing to provide their contact information and that of two friends/family members~* Permanent address for mailing of naloxone kit~* Does not currently have a naloxone kit in possession~Exclusion Criteria:~* Contraindication for naloxone (known severe allergic reaction)~* Cognitive impairment or unstable psychiatric condition that interferes with the informed consent process

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Opioid Overdose Education and Naloxone Distribution (Type: EXPERIMENTAL): Participants will engage in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm will be provided with a naloxone nasal spray kit (4mg).
- Opioid Overdose Education (Type: ACTIVE_COMPARATOR): Participants will engage in online audiovisual training focused on recognizing the signs of an opioid overdose and the procedural steps for how to administer naloxone. Participants randomized to this arm will receive information about pharmacies in their area where they can purchase a naloxone kit.

Based on this trial design, predict the completion outcome and termination type (if applicable).